Suppr超能文献

2005-2023 年衢州市流行性腮腺炎的流行病学特征及中断时间序列分析。

Epidemiological characteristics and interrupted time series analysis of mumps in Quzhou City, 2005-2023.

机构信息

Department of Epidemiology, School of Public Health, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China.

Department of Immunity, Quzhou Center for Disease Control and Prevention, Quzhou, Zhejiang, China.

出版信息

Hum Vaccin Immunother. 2024 Dec 31;20(1):2411828. doi: 10.1080/21645515.2024.2411828. Epub 2024 Oct 17.

Abstract

To analyze epidemiological characteristics of mumps in different periods and explore the impact of different immunization strategies of mumps containing vaccine (MuCV) on the incidence of mumps in Quzhou. We collected reported cases of mumps in Quzhou from 2005 to 2023 for descriptive epidemiological analysis. Interrupted time series (ITS) analysis was used to assess changes in mumps incidence during the one-dose, two-dose, and the three-dose MuCV vaccination period. From 2005 to 2023, a total of 10,295 cases of mumps were reported. The average annual reported incidence rates during three period, were 57.5/100,000 (7015 cases), 14.8/100,000 (2590 cases), and 6/100,000 (690 cases), respectively. The male-to-female ratio reported cases was 1.58:1, and most cases were aged 5-9 years, accounting for 43.7%. ITS analysis showed an immediate decrease in monthly mumps incidence of 3.3951/100,000 after two-dose MuCV vaccination period ( = .022). However, the monthly mumps incidence only decreased by 0.1191/100,000 immediately after the implementation of the three doses of MMR vaccination ( = .411). The monthly incidence of mumps showed a slight increase of 0.0052/100,000 in the one-dose vaccination period, followed by a decrease of 0.0126/100,000 in the two-dose vaccination period, and a further decrease of 0.0004/100,000 in the three-dose MMR period ( > .05). This study shows that timely introduction of two doses of MuCV and ensuring high vaccination coverage are beneficial in controlling mumps epidemics. Currently, the key populations affected are children and adolescents, emphasizing the importance of addressing outbreaks within school epidemics.

摘要

分析不同时期流行性腮腺炎的流行病学特征,探讨不同含腮腺炎疫苗(MuCV)的免疫策略对衢州市流行性腮腺炎发病率的影响。我们对 2005 年至 2023 年衢州市报告的流行性腮腺炎病例进行描述性流行病学分析。采用中断时间序列(ITS)分析评估单剂、双剂和三剂 MuCV 接种期间流行性腮腺炎发病率的变化。2005 年至 2023 年,共报告流行性腮腺炎 10295 例。3 个时期的年平均报告发病率分别为 57.5/100000(7015 例)、14.8/100000(2590 例)和 6/100000(690 例)。报告病例的男女性别比为 1.58:1,多数病例为 5-9 岁,占 43.7%。ITS 分析显示,双剂 MuCV 接种后,每月流行性腮腺炎发病率立即下降 3.3951/100000( = .022)。然而,实施三剂 MMR 疫苗接种后,每月流行性腮腺炎发病率仅立即下降 0.1191/100000( = .411)。单剂接种后,流行性腮腺炎每月发病率略有上升 0.0052/100000,双剂接种后下降 0.0126/100000,三剂 MMR 接种后进一步下降 0.0004/100000( > .05)。本研究表明,及时引入两剂 MuCV 并确保高疫苗接种率有利于控制流行性腮腺炎疫情。目前,受影响的关键人群是儿童和青少年,这强调了在学校疫情中处理暴发的重要性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验